Ameriprise’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.19M | Sell |
19,802
-1,196
| -6% | -$220K | ﹤0.01% | 2669 |
|
|
2026
Q1 | $3.35M | Sell |
20,998
-1,269
| -6% | -$195K | ﹤0.01% | 2693 |
|
|
2025
Q4 | $3.05M | Sell |
22,267
-1,133
| -5% | -$146K | ﹤0.01% | 2772 |
|
|
2025
Q3 | $2.84M | Sell |
23,400
-1,314
| -5% | -$142K | ﹤0.01% | 2797 |
|
|
2025
Q2 | $2.65M | Sell |
24,714
-1,406
| -5% | -$141K | ﹤0.01% | 2789 |
|
|
2025
Q1 | $2.42M | Sell |
26,120
-1,094
| -4% | -$106K | ﹤0.01% | 2799 |
|
|
2024
Q4 | $2.93M | Sell |
27,214
-2,672
| -9% | -$325K | ﹤0.01% | 2715 |
|
|
2024
Q3 | $3.76M | Sell |
29,886
-6,499
| -18% | -$817K | ﹤0.01% | 2568 |
|
|
2024
Q2 | $3.94M | Sell |
36,385
-1,855
| -5% | -$181K | ﹤0.01% | 2480 |
|
|
2024
Q1 | $3.61M | Sell |
38,240
-9,315
| -20% | -$882K | ﹤0.01% | 2565 |
|
|
2023
Q4 | $4.4M | Sell |
47,555
-78,922
| -62% | -$6.05M | ﹤0.01% | 2455 |
|
|
2023
Q3 | $8.09M | Sell |
126,477
-3,500
| -3% | -$224K | ﹤0.01% | 1877 |
|
|
2023
Q2 | $8.04M | Buy |
129,977
+113,625
| +695% | +$6.74M | ﹤0.01% | 1975 |
|
|
2023
Q1 | $950K | Buy |
16,352
+4,705
| +40% | +$270K | ﹤0.01% | 3177 |
|
|
2022
Q4 | $693K | Buy |
+11,647
| New | +$706K | ﹤0.01% | 3282 |
|
|
2020
Q4 | – | Sell |
-4,941
| Closed | -$308K | – | 3808 |
|
|
2020
Q3 | $308K | Buy |
+4,941
| New | +$309K | ﹤0.01% | 3418 |
|
|
2020
Q2 | – | Sell |
-2,767
| Closed | -$200K | – | 3718 |
|
|
2020
Q1 | $200K | Buy |
+2,767
| New | +$219K | ﹤0.01% | 3438 |
|
|
2019
Q2 | – | Sell |
-3,512
| Closed | -$268K | – | 3759 |
|
|
2019
Q1 | $268K | Sell |
3,512
-103
| -3% | -$8.17K | ﹤0.01% | 3479 |
|
|
2018
Q4 | $285K | Buy |
3,615
+3,573
| +8,507% | +$280K | ﹤0.01% | 3369 |
|
|
2018
Q3 | $3K | Buy |
+42
| New | +$3.09K | ﹤0.01% | 3712 |
|
|
2014
Q4 | – | Sell |
-1,435
| Closed | -$80K | – | 4157 |
|
|
2014
Q3 | $80K | Sell |
1,435
-2,660
| -65% | -$150K | ﹤0.01% | 3778 |
|
|
2014
Q2 | $231K | Sell |
4,095
-860
| -17% | -$46.8K | ﹤0.01% | 3260 |
|
|
2014
Q1 | $277K | Buy |
4,955
+2,585
| +109% | +$135K | ﹤0.01% | 3134 |
|
|
2013
Q4 | $128K | Sell |
2,370
-760
| -24% | -$38.9K | ﹤0.01% | 3308 |
|
|
2013
Q3 | $149K | Buy |
3,130
+2,160
| +223% | +$103K | ﹤0.01% | 3298 |
|
|
2013
Q2 | $46K | Buy |
+970
| New | +$45.3K | ﹤0.01% | 3757 |
|
Other funds holding NHC
MSIIA
Ameriprise's NHC Position: Q2 2026 in Review
Ameriprise reduced its National Healthcare (NHC) stake by 5.7% in Q2 2026, selling an estimated $220K and leaving 19,802 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2669.
Ameriprise first reported a position in NHC in Q2 2013 and has held it in 26 quarters since. The position peaked at $8.09M in Q3 2023. 248 funds tracked by Wall St. Rank hold NHC as of Q2 2026.
- Ameriprise held 19,802 shares of National Healthcare worth $4.19M as of Q2 2026.
- Ameriprise sold 1,196 National Healthcare shares in Q2 2026, an estimated $220K.
- National Healthcare made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2669 holding.
- Ameriprise first reported a position in National Healthcare in Q2 2013 and has held it in 26 quarters since.
- Ameriprise's National Healthcare position peaked at $8.09M in Q3 2023.
- 248 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.